GlaxoSmithKline and Medicago Team Up to Develop COVID-19 Vaccine  GSK, Medicago Forge Agreement to Develop Novel Adjuvanted COVID-19 Vaccine based on Medicago's Virus-Like Particle (VLP) technology  $GSK $MRNA $JNJ $AZN #vaccine #stockmarket #investment